Profile data is unavailable for this security.
About the company
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
- Revenue in USD (TTM)83.81m
- Net income in USD22.48m
- Incorporated2014
- Employees160.00
- LocationIRadimed Corp12705 Ingenuity DriveORLANDO 32826United StatesUSA
- Phone+1 (407) 677-8022
- Fax+1 (302) 636-5454
- Websitehttps://www.iradimed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inmode Ltd | 370.50m | 93.83m | 906.03m | 660.00 | 9.91 | 1.33 | 9.58 | 2.45 | 1.44 | 1.44 | 5.67 | 10.78 | 0.4774 | 1.19 | 9.28 | 561,356.10 | 12.09 | 24.21 | 13.30 | 26.82 | 78.54 | 82.36 | 25.33 | 38.64 | 8.83 | -- | 0.00 | 0.00 | -6.16 | 12.44 | -48.24 | 4.57 | 15.99 | -- |
| Castle Biosciences Inc | 343.53m | -12.24m | 931.12m | 761.00 | -- | 1.99 | 30.50 | 2.71 | -0.4533 | -0.4533 | 11.67 | 16.02 | 0.6377 | 9.05 | 6.89 | 451,419.20 | -2.27 | -6.95 | -2.50 | -7.52 | 79.94 | 80.76 | -3.56 | -17.49 | 6.31 | -- | 0.0218 | -- | 51.09 | 44.97 | 131.75 | 43.57 | 97.74 | -- |
| BioLife Solutions Inc | 88.83m | -13.99m | 1.04bn | 159.00 | -- | 2.93 | -- | 11.70 | -0.2922 | -0.061 | 1.87 | 7.37 | 0.2296 | 0.8875 | 6.18 | 558,698.10 | -3.62 | -1.92 | -3.92 | -2.10 | 70.02 | 52.54 | -15.75 | -9.06 | 3.64 | -- | 0.0207 | -- | 8.44 | 24.62 | 38.27 | -- | 19.15 | -- |
| Enovis Corp | 2.23bn | -1.37bn | 1.25bn | 7.37k | -- | 0.6201 | -- | 0.5611 | -24.20 | -24.20 | 39.35 | 35.33 | 0.4474 | 1.56 | 5.37 | 303,144.60 | -27.38 | -3.14 | -30.81 | -3.56 | 57.19 | 52.01 | -61.19 | -9.77 | 1.16 | 0.0495 | 0.4018 | -- | 23.46 | -8.73 | -1,423.10 | -- | 7.58 | -- |
| Tandem Diabetes Care Inc | 1.01bn | -203.37m | 1.27bn | 2.65k | -- | 9.53 | -- | 1.26 | -3.05 | -3.05 | 15.08 | 1.96 | 1.10 | 3.25 | 8.64 | 380,000.40 | -22.20 | -10.11 | -30.80 | -12.33 | 53.23 | 51.67 | -20.20 | -11.71 | 1.90 | -9.88 | 0.7028 | -- | 25.74 | 21.01 | 56.86 | -- | 27.42 | -- |
| Iradimed Corp | 83.81m | 22.48m | 1.27bn | 160.00 | 57.07 | 13.42 | 75.50 | 15.15 | 1.75 | 1.75 | 6.52 | 7.44 | 0.8094 | -- | -- | -- | 21.71 | 18.06 | 23.86 | 20.21 | 76.75 | 76.85 | 26.82 | 25.51 | -- | -- | -- | -- | 14.43 | 21.45 | 16.88 | 108.61 | -- | -- |
| Conmed Corp | 1.37bn | 47.06m | 1.29bn | 3.90k | 27.50 | -- | 10.64 | 0.9387 | 1.52 | 1.52 | 44.24 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 54.08 | 55.56 | 3.42 | 3.78 | -- | 3.24 | -- | -- | 5.18 | 9.77 | -64.47 | 37.66 | -- | -5.59 |
| Adapthealth Corp | 3.26bn | 75.81m | 1.37bn | 10.50k | 18.17 | 0.8452 | 2.87 | 0.4198 | 0.5553 | 0.5553 | 23.90 | 11.94 | 0.7354 | 17.20 | 8.33 | 310,020.30 | 1.96 | -2.81 | 2.28 | -3.17 | 25.32 | 19.63 | 2.67 | -4.19 | 0.8584 | 2.30 | 0.5253 | -- | 1.90 | 43.84 | 112.19 | -- | 70.36 | -- |
| Novocure Ltd | 642.27m | -177.65m | 1.40bn | 1.49k | -- | 4.11 | -- | 2.18 | -1.61 | -1.61 | 5.81 | 3.05 | 0.4973 | 4.01 | 8.43 | 431,632.40 | -13.75 | -9.61 | -33.14 | -11.84 | 75.57 | 77.57 | -27.66 | -19.32 | 1.50 | -- | 0.6887 | -- | 18.82 | 11.49 | 18.55 | -- | 32.52 | -- |
| Procept Biorobotics Corp | 299.91m | -84.58m | 1.57bn | 756.00 | -- | 4.13 | -- | 5.23 | -1.54 | -1.54 | 5.45 | 6.81 | 0.6772 | 1.81 | 3.91 | 396,702.40 | -19.10 | -26.94 | -21.74 | -29.81 | 64.55 | 54.37 | -28.20 | -83.14 | 7.20 | -- | 0.1194 | -- | 64.84 | 105.21 | 13.68 | -- | -10.34 | -- |
| AtriCure Inc | 518.31m | -28.77m | 1.58bn | 1.30k | -- | 3.32 | -- | 3.05 | -0.608 | -0.608 | 10.90 | 9.59 | 0.829 | 1.68 | 8.79 | 398,696.20 | -4.60 | -3.84 | -5.24 | -4.25 | 74.87 | 74.53 | -5.55 | -7.13 | 2.85 | -17.96 | 0.1252 | -- | 16.55 | 15.05 | -46.85 | -- | 14.00 | -- |
| Pulse Biosciences Inc | 86.00k | -74.73m | 1.59bn | 75.00 | -- | 17.10 | -- | 18,439.09 | -1.14 | -1.14 | 0.0013 | 1.37 | 0.0009 | -- | -- | 1,146.67 | -74.06 | -83.75 | -80.63 | -94.40 | -224.42 | -- | -86,898.84 | -12,644.52 | 10.01 | -- | 0.00 | -- | -- | -- | -26.95 | -- | -27.12 | -- |
| Kestra Medical Technologies Ltd | 74.26m | -138.79m | 1.60bn | 330.00 | -- | 8.61 | -- | 21.58 | -2.76 | -2.76 | 1.47 | 3.19 | 0.4034 | -- | 9.40 | 225,027.30 | -71.43 | -122.23 | -92.37 | -192.35 | 46.40 | -- | -177.06 | -342.51 | -- | -116.72 | 0.2033 | -- | 115.05 | -- | -25.08 | -- | 150.61 | -- |
| Quidelortho Corp | 2.73bn | -1.13bn | 1.61bn | 6.60k | -- | 0.8396 | -- | 0.5906 | -16.66 | -16.66 | 40.27 | 28.27 | 0.4478 | 2.62 | 7.46 | -- | -18.56 | -6.45 | -22.13 | -7.39 | 46.67 | 53.89 | -41.45 | -14.40 | 0.9002 | 0.6757 | 0.5798 | -- | -1.89 | 10.44 | 44.84 | -- | -- | -- |
| Omnicell Inc | 1.18bn | 2.05m | 1.62bn | 3.60k | 836.92 | 1.32 | 19.83 | 1.37 | 0.0432 | 0.0432 | 25.70 | 27.45 | 0.5786 | 7.19 | 5.01 | -- | 0.1002 | 0.7331 | 0.1357 | 0.9767 | 42.49 | 44.80 | 0.1732 | 1.32 | 1.22 | -- | 0.1198 | -- | 6.53 | 5.84 | -83.62 | -42.34 | 1.93 | -- |
Data as of Feb 13 2026. Currency figures normalised to IRadimed Corp's reporting currency: US Dollar USD
29.62%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nine Ten Capital Management LLCas of 30 Sep 2025 | 771.38k | 6.06% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 669.62k | 5.26% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 495.77k | 3.90% |
| Renaissance Technologies LLCas of 30 Sep 2025 | 488.76k | 3.84% |
| Copeland Capital Management LLCas of 31 Dec 2025 | 412.55k | 3.24% |
| Geode Capital Management LLCas of 30 Sep 2025 | 266.34k | 2.09% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 200.67k | 1.58% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 187.24k | 1.47% |
| Acadian Asset Management LLCas of 30 Sep 2025 | 145.28k | 1.14% |
| BlackRock Financial Management, Inc.as of 30 Sep 2025 | 130.78k | 1.03% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
